Changes in the trends of initial treatment for newly diagnosed prostate cancer in Japan: a nationwide multi-institutional study.
Taketo KawaiMizuki OnozawaSatoru TaguchiMasaki ShiotaShinichi SakamotoYoshiyuki YamamotoYasuhide KitagawaTohru NakagawaShiro HinotsuHaruki Kumenull nullPublished in: Japanese journal of clinical oncology (2024)
In Japan, RP and RT have increased as initial treatments for prostate cancer, whereas ADT has decreased. Consequently, RP has emerged as the most commonly selected initial treatment, replacing ADT.